APA (7th ed.) Citation

Yamamoto, M., Kiso, M., Sakai-Tagawa, Y., Iwatsuki-Horimoto, K., Imai, M., Takeda, M., . . . Inoue, J. (2020). The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner. Viruses, 12(6), 629. https://doi.org/10.3390/v12060629

Chicago Style (17th ed.) Citation

Yamamoto, Mizuki, et al. "The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner." Viruses 12, no. 6 (2020): 629. https://doi.org/10.3390/v12060629.

MLA (9th ed.) Citation

Yamamoto, Mizuki, et al. "The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner." Viruses, vol. 12, no. 6, 2020, p. 629, https://doi.org/10.3390/v12060629.